These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3304347)

  • 1. Milan as possible starting point of LAV/HTLV III epidemic among Italian drug addicts.
    Lazzarin A; Crocchiolo P; Galli M; Uberti Foppa C; Caredda F; Re T; Moroni M
    Boll Ist Sieroter Milan; 1987; 66(1):9-13. PubMed ID: 3304347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevalence of antibodies against HTLV-III/LAV in homosexuals and drug addicts from a population in Madrid].
    Alós JI; Rodríguez-Créixems M; Guerrero A; Gómez-Criado C; Romero-Vivas J; Bouza E
    Rev Clin Esp; 1986 Sep; 179(4):172-4. PubMed ID: 3464056
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of HTLV-III/LAV antibody in selected populations in Thailand.
    Wangroongsarb Y; Weniger BG; Wasi C; Traisupa A; Kunasol P; Rojanapithayakorn W; Fucharoen S
    Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):517-20. PubMed ID: 3869739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case reports of 77 HTLV III/LAV-positive patients observed during one-year period. Preliminary note].
    Soranzo ML; Salassa B; Daziano E; Paggi GC
    Minerva Med; 1986 May; 77(20):897-900. PubMed ID: 3014379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunological profile of drug addicts: HTLV-III negative, HTLV-III positive and those with lymphadenopathy syndrome-AIDS related complex].
    Cascavilla N; Martini E; Melillo L; Musto P; Nobile M; Valori VM; Di Giorgio G; Carotenuto M
    Recenti Prog Med; 1987 Mar; 78(3):108-12. PubMed ID: 3648856
    [No Abstract]   [Full Text] [Related]  

  • 6. [Increase in the prevalence of antibodies against LAV/HTLV III in drug addicts in West Germany].
    Zoulek G; Gürtler L; Eberle J; Lorbeer B; Deinhardt F
    Dtsch Med Wochenschr; 1986 Apr; 111(15):567-70. PubMed ID: 3007065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HTLV-III serology, epidemiology and clinical aspects of imprisoned i.v. drug-dependent males in Austria].
    Pont J; Neuwald C; Kunz C; Werdenich W
    Wien Klin Wochenschr; 1986 Jul; 98(14):454-7. PubMed ID: 3019019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report.
    Levy N; Carlson JR; Hinrichs S; Lerche N; Schenker M; Gardner MB
    N Engl J Med; 1986 Feb; 314(7):446. PubMed ID: 3456077
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
    Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of HTLV III/LAV and other viral antibodies in normal and at risk populations.
    Ferrante P; Nardi G; Zanchetta N; Salvioni PM; Pagano A
    Boll Ist Sieroter Milan; 1986; 65(5):357-60. PubMed ID: 3030363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LAV/HTLV-III infection among a group of homosexual men; prevalence and psychosocial factors].
    van Griensven GJ; Tielman RA; Goudsmit J; van der Noordaa J; de Wolf F; Coutinho RA
    Ned Tijdschr Geneeskd; 1986 Nov; 130(48):2178-80. PubMed ID: 3492678
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)].
    Bedarida G; D'Agostino F; Ronsivalle MG; Berto E; Cambiè G; Berto N; Grisi ME; Arcidiacono I; Sterza G
    Riv Emoter Immunoematol; 1986; 33(1):75-87. PubMed ID: 3532290
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prevalence and morbidity of HTLV-III/LAV infection in homosexuals and parenteral drug addicts (up-date 1985)].
    Cárcaba V; Fernández-León A; Cartón JA; Palacio V
    Med Clin (Barc); 1987 Jan; 88(3):123-4. PubMed ID: 3821277
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemic of LAV/HTLV III infection in drug addicts in Milan: serological survey and clinical follow-up.
    Lazzarin A; Galli M; Geroldi D; Zanetti A; Crocchiolo P; Aiuti F; Moroni M
    Infection; 1985; 13(5):216-8. PubMed ID: 2999002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-III infection in Canada in 1985.
    Neumann PW; Benning BJ; Robinson DG; Gilmore N; O'Shaughnessy MV
    CMAJ; 1986 Sep; 135(5):477-80. PubMed ID: 3461870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired immunodeficiency syndrome and HTLV-III/LAV infection.
    Rogers MF; Lifson AR
    Semin Adolesc Med; 1986 Jun; 2(2):163-73. PubMed ID: 3474746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies anti-HTLV III and lymphocyte subsets of high risk subjects.
    Ripa S; Mignini F; Anichini M; Casprini P; Prenna M
    Boll Ist Sieroter Milan; 1987; 66(2):101-5. PubMed ID: 3663335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Occurrence of HTLV-III infection and related clinical forms in a homogeneous group of drug addicts. Significance of immunologic changes and evaluation of risk factors].
    Tassinari MC; Gualandi M; Guerra G; Barbieri D; Benassi N; Lazzarato M; Dallara G; Gallerani M
    Recenti Prog Med; 1986 Oct; 77(10):461-5. PubMed ID: 3547522
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for antibody to HTLV-III in blood donors of Liguria. Ligurian Committee for the Study of Infections Transmitted through Blood and Blood Products.
    Boll Ist Sieroter Milan; 1985; 64(5):363-6. PubMed ID: 3004542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing prevalence of HTLV-III infection in intravenous drug users in Liguria, Italy.
    Cuneo Crovari P; Terragna A; Robert L; Orlando G; Rizzo F; Piuma-Fusco M; Icardi GC; Papa D; Di Ponzio A; Auteri G
    Boll Ist Sieroter Milan; 1985; 64(4):339-42. PubMed ID: 3000406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.